A Study for Participants With Major Depression

NCT00420004 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

469

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: LY2216684
DRUG: Placebo
DRUG: Escitalopram

Sponsor

Eli Lilly and Company